叶黄素
医学
奥沙利铂
吉西他滨
伊立替康
肿瘤科
内科学
临床试验
胰腺癌
氟尿嘧啶
无进展生存期
结直肠癌
癌症
化疗
作者
Federico Nichetti,Simone Rota,Paolo Ambrosini,Chiara Pircher,Eleonora Gusmaroli,Michele Droz Dit Busset,Sara Pusceddu,Carlo Sposito,Jorgelina Coppa,Federica Morano,Filippo Pietrantonio,Maria Di Bartolomeo,Luigi Mariani,Vincenzo Mazzaferro,Filippo de Braud,Monica Niger
出处
期刊：JAMA network open
[American Medical Association]
日期：2024-01-08
卷期号：7 (1): e2350756-e2350756
被引量：42
标识
DOI：10.1001/jamanetworkopen.2023.50756
摘要
The NAPOLI 3 trial showed the superiority of fluorouracil, leucovorin, liposomal irinotecan, and oxaliplatin (NALIRIFOX) over the combination of gemcitabine and nab-paclitaxel (GEM-NABP) as first-line treatment of metastatic pancreatic ductal adenocarcinoma (PDAC). Analyses comparing NALIRIFOX and GEM-NABP with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) have not yet been reported.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
GingerF
核桃
404NotFOUND
浮游
Magali
大力的灭绝
LaTeXer
遇上就这样吧
tuanzi233
加菲丰丰
华仔
竹筏过海
兔兔兔
郎泽昆
CAOHOU
ccm
脑洞疼
CodeCraft
个性的紫菜
正己化人
皖公网安备34019202002308
